Home >> Expert Opinion on Drug Safety, Volume 2, Number 5
Expert Opinion on Drug Safety logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 2, Number 5, 1 September 2003

< previous issue | all issues | next issue >

Editorial

Detection of drug-related adverse events in hospitals
pp. 447-449(3)
Authors: Thürmann P.A.

Miscellaneous

Recent differing expert opinions regarding the safety profile of hepatitis B vaccines: is there really a controversy?
pp. 451-455(5)
Author: Pless R.P.

Review article

Long-term safety of tacrolimus ointment in children treated for atopic dermatitis
pp. 457-465(9)
Authors: Shainhouse T.; Eichenfield L.F.

Skin reactions related to treatment with anticytokines, membrane receptor inhibitors and monoclonal antibodies
pp. 467-473(7)
Author: Dereure O.

Antifungal drugs in pregnancy: a review
pp. 475-483(9)
Authors: Moudgal V.V.; Sobel J.D.

The safety of SSRIs in generalised anxiety disorder: any reason to be anxious?
pp. 485-493(9)
Authors: Masand P.S.; Gupta S.

Medication-induced oesophageal disorders
pp. 495-507(13)
Authors: Petersen K-U.; Jaspersen D.

Meeting report

Problems and perils of prescription medicines
pp. 509-511(3)
Author: Richards D.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page